- Instruments
- Automated culture systems
- Microbiology analysers
- Reagents
Automated Microbiology Market size was valued at USD 7,189.2 million in 2023 and growing at a CAGR of 9.5% from 2024 -2030. Automated microbiology is a cutting-edge technique that improves the accuracy and efficiency of molecular testing while accelerating the transfer of disease diagnostic data. Automated microbiology systems offer a fundamental structure for recognizing pathogens and quickly identifying different infectious agents, such as bacteria, fungi, viruses, and prions. The key factors fuelling the market are the rising incidence of infectious diseases, increasing demand for rapid diagnostic techniques, and technological advancements in automation are accountable for the market growth.
For instance, with the implementation of the BD Kiestra TLA system, the University Hospitals Cleveland Medical Centre observed a 20% decrease in personnel needs. This decrease highlights how automation can save costs and improve productivity in microbiology labs. However, the high cost of automated systems, limited skilled personnel and integration challenges are the limiting factors for the industry.
Furthermore, advancements in technology like artificial intelligence and machine learning, robotics in accumulation to automation, and healthcare infrastructure development are opportunities. In addition, increased adoption of molecular diagnostics, high-efficiency screening, focus on infection control, data analytics and integration, and point-of-care testing are the market trends for the automated microbiology market.
Automated Microbiology Market Key Developments
- In June 2024, The BD BACTEC FX40 is an advanced automated blood culture device that was introduced by Becton, Dickinson, and Company to enhance pathogen detection.
- In May 2024, to improve lab workflow efficiency, bioMérieux introduced VITEK MS PRIME, a new automated microbiology platform.
- In November 2019, BD Kiestra IdentifA system was introduced by Becton, Dickinson and Company. This method efficiently and accurately prepares samples for microbiological identification
Automated Microbiology Market Summary
Study Period
2024 - 2030Base Year
2023CAGR
9.5%Largest Market
North AmericaFastest Growing Market
North AmericaAutomated Microbiology Market Dynamics
The worldwide automated microbiology market is expected to increase as a result of the rising occurrence of viral diseases. To identify pathogens, automated microbiology has grown rapidly in the last several years. This is because it aids in the early detection of a wide range of infectious agents, such as bacteria, fungi, viruses, parasites, and prion-like organisms. The growing emphasis on automation advancement in laboratory settings, the growing demand for error-free test results from microbiological tests, and the rising amount of money invested to advance the field of microbiology research are additional significant factors contributing to the growth of the global automated microbiology market.
North America dominates the market
Automated Microbiology Market Regional Analysis
Based on regions, the market is segmented into North America, Europe, Asia-Pacific, Latin America, and Middle East and Africa.
North America dominates the automated microbiology market. The region's high frequency of infectious diseases, substantial investment in research and development, and sophisticated healthcare infrastructure all contribute to its domination. When it comes to the widespread use of automated microbiological systems in clinical laboratories and hospitals to increase the precision and effectiveness of diagnostics, the United States and Canada are market leaders. The market for automated microbiology is dominated by Europe due to its strict regulatory framework and strong emphasis on enhancing healthcare outcomes. The region's significant market share is supported by its dedication to laboratory automation and healthcare innovation
Latin America
Europe
Asia Pacific
Middle East
North America
Automated Microbiology Market Segmentation
By Product Type
By Diagnostic Technology
- DNA sequencing
- DNA & RNA probe technology
- Detection techniques
- Monoclonal antibodies
- Immunoassays
By End-user
- Hospitals
- Clinical Laboratories
- Biotechnology industries
- Blood banks
Frequently Asked Questions
The Automated Microbiology Market is valued at USD 7,189.2 million in 2023 and growing at a CAGR of 9.5%.
North America dominates the automated microbiology market. The region's high frequency of infectious diseases, substantial investment in research and development, and sophisticated healthcare infrastructure all contribute to its domination.
The advancements in technology like artificial intelligence and machine learning, robotics in accumulation to automation, and healthcare infrastructure development.
The Automated Microbiology Market is segmented based on Product, Diagnostic Technology, End-Use, and Region
Key Features of the Report
- The automated microbiology market report provides granular level information about the market size, regional market share, historic market (2019-2023), and forecast (2024-2030)
- The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and key strategies.
- The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market.
- The report tracks recent innovations, key developments, and start-up details that are actively working in the market.
- The report provides a plethora of information about market entry strategies, regulatory framework, and reimbursement scenarios.
| 1. Executive Summary |
| 2. Global Automated Microbiology Market Introduction |
| 2.1. Global Automated Microbiology Market - Taxonomy |
| 2.2. Global Automated Microbiology Market - Definitions |
| 2.2.1.Product Type |
| 2.2.2.Diagnostic Technology |
| 2.2.3.End Users |
| 2.2.4.Region |
| 3. Global Automated Microbiology Market Dynamics |
| 3.1. Drivers |
| 3.2. Restraints |
| 3.3. Opportunities/Unmet Needs of the Market |
| 3.4. Trends |
| 3.5. Product Landscape |
| 3.6. New Product Launches |
| 3.7. Impact of COVID 19 on Market |
| 4. Global Automated Microbiology Market Analysis, 2019 - 2023 and Forecast 2024 - 2030 |
| 4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) |
| 4.3. Market Opportunity Analysis |
| 5. Global Automated Microbiology Market By Product Type, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 5.1. Instruments |
| 5.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.1.3. Market Opportunity Analysis |
| 5.2. Automated culture systems |
| 5.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.2.3. Market Opportunity Analysis |
| 5.3. Microbiology analysers |
| 5.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.3.3. Market Opportunity Analysis |
| 5.4. Reagents |
| 5.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 5.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.4.3. Market Opportunity Analysis |
| 6. Global Automated Microbiology Market By Diagnostic Technology, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 6.1. DNA sequencing |
| 6.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.1.3. Market Opportunity Analysis |
| 6.2. DNA & RNA probe technology |
| 6.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.2.3. Market Opportunity Analysis |
| 6.3. Detection techniques |
| 6.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.3.3. Market Opportunity Analysis |
| 6.4. Monoclonal antibodies |
| 6.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 6.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.4.3. Market Opportunity Analysis |
| 6.5. Immunoassays |
| 6.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 6.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.5.3. Market Opportunity Analysis |
| 7. Global Automated Microbiology Market By End Users, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 7.1. Hospitals |
| 7.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.1.3. Market Opportunity Analysis |
| 7.2. Clinical Laboratories |
| 7.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.2.3. Market Opportunity Analysis |
| 7.3. Biotechnology industries |
| 7.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.3.3. Market Opportunity Analysis |
| 7.4. Blood banks |
| 7.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 7.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.4.3. Market Opportunity Analysis |
| 8. Global Automated Microbiology Market By Region, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 8.1. North America |
| 8.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.1.3. Market Opportunity Analysis |
| 8.2. Europe |
| 8.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.2.3. Market Opportunity Analysis |
| 8.3. Asia Pacific (APAC) |
| 8.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.3.3. Market Opportunity Analysis |
| 8.4. Middle East and Africa (MEA) |
| 8.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 8.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.4.3. Market Opportunity Analysis |
| 8.5. Latin America |
| 8.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 8.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.5.3. Market Opportunity Analysis |
| 9. North America Automated Microbiology Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 9.1. Product Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.1.1.Instruments |
| 9.1.2.Automated culture systems |
| 9.1.3.Microbiology analysers |
| 9.1.4.Reagents |
| 9.2. Diagnostic Technology Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.2.1.DNA sequencing |
| 9.2.2.DNA & RNA probe technology |
| 9.2.3.Detection techniques |
| 9.2.4.Monoclonal antibodies |
| 9.2.5.Immunoassays |
| 9.3. End Users Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.3.1.Hospitals |
| 9.3.2.Clinical Laboratories |
| 9.3.3.Biotechnology industries |
| 9.3.4.Blood banks |
| 9.4. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.4.1.United States of America (USA) |
| 9.4.2.Canada |
| 10. Europe Automated Microbiology Market, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 10.1. Product Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.1.1.Instruments |
| 10.1.2.Automated culture systems |
| 10.1.3.Microbiology analysers |
| 10.1.4.Reagents |
| 10.2. Diagnostic Technology Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.2.1.DNA sequencing |
| 10.2.2.DNA & RNA probe technology |
| 10.2.3.Detection techniques |
| 10.2.4.Monoclonal antibodies |
| 10.2.5.Immunoassays |
| 10.3. End Users Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.3.1.Hospitals |
| 10.3.2.Clinical Laboratories |
| 10.3.3.Biotechnology industries |
| 10.3.4.Blood banks |
| 10.4. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.4.1.Germany |
| 10.4.2.France |
| 10.4.3.Italy |
| 10.4.4.United Kingdom (UK) |
| 10.4.5.Spain |
| 10.4.6.Rest of EU |
| 11. Asia Pacific (APAC) Automated Microbiology Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 11.1. Product Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.1.1.Instruments |
| 11.1.2.Automated culture systems |
| 11.1.3.Microbiology analysers |
| 11.1.4.Reagents |
| 11.2. Diagnostic Technology Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.2.1.DNA sequencing |
| 11.2.2.DNA & RNA probe technology |
| 11.2.3.Detection techniques |
| 11.2.4.Monoclonal antibodies |
| 11.2.5.Immunoassays |
| 11.3. End Users Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.3.1.Hospitals |
| 11.3.2.Clinical Laboratories |
| 11.3.3.Biotechnology industries |
| 11.3.4.Blood banks |
| 11.4. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.4.1.China |
| 11.4.2.India |
| 11.4.3.Australia and New Zealand (ANZ) |
| 11.4.4.Japan |
| 11.4.5.Rest of APAC |
| 12. Middle East and Africa (MEA) Automated Microbiology Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 12.1. Product Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.1.1.Instruments |
| 12.1.2.Automated culture systems |
| 12.1.3.Microbiology analysers |
| 12.1.4.Reagents |
| 12.2. Diagnostic Technology Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.2.1.DNA sequencing |
| 12.2.2.DNA & RNA probe technology |
| 12.2.3.Detection techniques |
| 12.2.4.Monoclonal antibodies |
| 12.2.5.Immunoassays |
| 12.3. End Users Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.3.1.Hospitals |
| 12.3.2.Clinical Laboratories |
| 12.3.3.Biotechnology industries |
| 12.3.4.Blood banks |
| 12.4. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.4.1.GCC Countries |
| 12.4.2.South Africa |
| 12.4.3.Rest of MEA |
| 13. Latin America Automated Microbiology Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 13.1. Product Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.1.1.Instruments |
| 13.1.2.Automated culture systems |
| 13.1.3.Microbiology analysers |
| 13.1.4.Reagents |
| 13.2. Diagnostic Technology Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.2.1.DNA sequencing |
| 13.2.2.DNA & RNA probe technology |
| 13.2.3.Detection techniques |
| 13.2.4.Monoclonal antibodies |
| 13.2.5.Immunoassays |
| 13.3. End Users Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.3.1.Hospitals |
| 13.3.2.Clinical Laboratories |
| 13.3.3.Biotechnology industries |
| 13.3.4.Blood banks |
| 13.4. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.4.1.Brazil |
| 13.4.2.Mexico |
| 13.4.3.Rest of LA |
| 14. Competition Landscape |
| 14.1. Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) |
| 14.2.1.Abbott Laboratories |
| 14.2.2.Affymetrix, Inc. |
| 14.2.3.Agilent Technologies, Inc. |
| 14.2.4.Beckman Coulter |
| 14.2.5.Becton Dickinson and Company |
| 14.2.6.bioMeriux, Inc. |
| 14.2.7.Bio-Rad Laboratories, Inc. |
| 14.2.8.Gene-Probe, Inc. |
| 14.2.9.QIAGEN GmbH |
| 15. Research Methodology |
| 16. Appendix and Abbreviations |
- Abbott Laboratories
- Affymetrix, Inc.
- Agilent Technologies, Inc.
- Beckman Coulter
- Becton Dickinson and Company
- bioMeriux, Inc.
- Bio-Rad Laboratories, Inc.
- Gene-Probe, Inc.
- QIAGEN GmbH